Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Nature Genetics volume 55, pages 1598–1607 (2023 )Cite this article Shr Hair Removal Machine Ipl Shr Laser
Several molecular and phenotypic algorithms exist that establish genotype–phenotype correlations, including facial recognition tools. However, no unified framework that investigates both facial data and other phenotypic data directly from individuals exists. We developed PhenoScore: an open-source, artificial intelligence-based phenomics framework, combining facial recognition technology with Human Phenotype Ontology data analysis to quantify phenotypic similarity. Here we show PhenoScore’s ability to recognize distinct phenotypic entities by establishing recognizable phenotypes for 37 of 40 investigated syndromes against clinical features observed in individuals with other neurodevelopmental disorders and show it is an improvement on existing approaches. PhenoScore provides predictions for individuals with variants of unknown significance and enables sophisticated genotype–phenotype studies by testing hypotheses on possible phenotypic (sub)groups. PhenoScore confirmed previously known phenotypic subgroups caused by variants in the same gene for SATB1, SETBP1 and DEAF1 and provides objective clinical evidence for two distinct ADNP-related phenotypes, already established functionally.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
European Journal of Human Genetics Open Access 06 November 2023
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
Receive 12 print issues and online access
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The used dataset in this study is not publicly available due to both IRB and General Data Protection Regulation (EU GDPR) restrictions because the data might be (partially) traceable. However, access to the data may be requested from the data availability committee by contacting the corresponding authors via e-mail with a research proposal, who will respond within 14 d.
The code of PhenoScore version 1.0.0 created during this study is freely available at https://github.com/ldingemans/PhenoScore ref. 83, to enable anyone to apply PhenoScore to their own dataset. Included in PhenoScore are the following two examples: the data for the SATB1 subgroups (positive example) and random data (negative example).
Vissers, LELM et al.A de novo paradigm for mental retardation.Nut.Genet.42, 1109–1112 (2010).
Article CAS PubMed Google Scholar
de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921–1929 (2012).
Rauch, A. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380, 1674–1682 (2012).
Article CAS PubMed Google Scholar
Gilissen, C. et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344–347 (2014).
Article CAS PubMed Google Scholar
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Article PubMed PubMed Central Google Scholar
Beaumont, R. N. & Wright, C. F. Estimating diagnostic noise in panel-based genomic analysis. Genet. Med. 24, 2042–2050 (2022).
Article CAS PubMed Google Scholar
McGuire, A. L. et al. The road ahead in genetics and genomics. Nat. Rev. Genet. 21, 581–596 (2020).
Article CAS PubMed PubMed Central Google Scholar
Logsdon, G. A., Vollger, M. R. & Eichler, E. E. Long-read human genome sequencing and its applications. Nat. Rev. Genet. 21, 597–614 (2020).
Article CAS PubMed PubMed Central Google Scholar
100,000 Genomes Project Pilot Investigators. et al.100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. N. Engl. J. Med. 385, 1868–1880 (2021).
Neveling, K. et al. Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping. Am. J. Hum. Genet. 108, 1423–1435 (2021).
Article CAS PubMed PubMed Central Google Scholar
Mantere, T. et al. Optical genome mapping enables constitutional chromosomal aberration detection. Am. J. Hum. Genet. 108, 1409–1422 (2021).
Article CAS PubMed PubMed Central Google Scholar
Schwarz, J. M., Rödelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
Article CAS PubMed Google Scholar
Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
Article CAS PubMed Google Scholar
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
Article CAS PubMed PubMed Central Google Scholar
Robinson, P. N. et al. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am. J. Hum. Genet. 83, 610–615 (2008).
Article CAS PubMed PubMed Central Google Scholar
Leite, A. J. D. C. et al. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil. PLoS ONE 17, e0266493 (2022).
Article CAS PubMed PubMed Central Google Scholar
Clift, K. et al. Patients’ views on variants of uncertain significance across indications. J. Community Genet. 11, 139–145 (2020).
Makhnoon, S., Garrett, L. T., Burke, W., Bowen, D. J. & Shirts, B. H. Experiences of patients seeking to participate in variant of uncertain significance reclassification research. J. Community Genet. 10, 189–196 (2019).
Van Dijk, S. et al. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J. Clin. Oncol. 24, 3672–3677 (2006).
Murray, M. L., Cerrato, F., Bennett, R. L. & Jarvik, G. P. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet. Med. 13, 998–1005 (2011).
Article CAS PubMed Google Scholar
Hamburg, M. A. & Collins, F. S. The path to personalized medicine. N. Engl. J. Med. 363, 301–304 (2010).
Article CAS PubMed Google Scholar
Ashley, E. A. Towards precision medicine. Nat. Rev. Genet. 17, 507–522 (2016).
Article CAS PubMed Google Scholar
Brittain, H. K., Scott, R. & Thomas, E. The rise of the genome and personalised medicine. Clin. Med. 17, 545–551 (2017).
Coudray, N. et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat. Med. 24, 1559–1567 (2018).
Article CAS PubMed PubMed Central Google Scholar
Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L. H. & Aerts, H. J. W. L. Artificial intelligence in radiology. Nat. Rev. Cancer 18, 500–510 (2018).
Article CAS PubMed PubMed Central Google Scholar
Killock, D. AI outperforms radiologists in mammographic screening. Nat. Rev. Clin. Oncol. 17, 134 (2020).
Lu, M. Y. et al. AI-based pathology predicts origins for cancers of unknown primary. Nature 594, 106–110 (2021).
Article CAS PubMed Google Scholar
Poplin, R. et al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol. 36, 983–987 (2018).
Article CAS PubMed Google Scholar
Sundaram, L. et al. Predicting the clinical impact of human mutation with deep neural networks. Nat. Genet. 50, 1161–1170 (2018).
Article CAS PubMed PubMed Central Google Scholar
Wick, R. R., Judd, L. M. & Holt, K. E. Performance of neural network basecalling tools for Oxford Nanopore sequencing. Genome Biol. 20, 129 (2019).
Article PubMed PubMed Central Google Scholar
Köhler, S. et al. Clinical diagnostics in human genetics with semantic similarity searches in ontologies. Am. J. Hum. Genet. 85, 457–464 (2009).
Article PubMed PubMed Central Google Scholar
Robinson, P. N. et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res. 24, 340–348 (2014).
Article CAS PubMed PubMed Central Google Scholar
Zemojtel, T. et al. Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome. Sci. Transl. Med. 6, 252ra123 (2014).
Article PubMed PubMed Central Google Scholar
Smedley, D. & Robinson, P. N. Phenotype-driven strategies for exome prioritization of human Mendelian disease genes. Genome Med. 7, 81 (2015).
Article PubMed PubMed Central Google Scholar
Smedley, D. et al. Next-generation diagnostics and disease-gene discovery with the Exomiser. Nat. Protoc. 10, 2004–2015 (2015).
Article CAS PubMed PubMed Central Google Scholar
Hsieh, T.-C. et al. PEDIA: prioritization of exome data by image analysis. Genet. Med. 21, 2807–2814 (2019).
Article PubMed PubMed Central Google Scholar
Robinson, P. N. et al. Interpretable clinical genomics with a likelihood ratio paradigm. Am. J. Hum. Genet. 107, 403–417 (2020).
Article CAS PubMed PubMed Central Google Scholar
Ferry, Q. et al. Diagnostically relevant facial gestalt information from ordinary photos. eLife 3, e02020 (2014).
Article PubMed PubMed Central Google Scholar
Dudding-Byth, T. et al. Computer face-matching technology using two-dimensional photographs accurately matches the facial gestalt of unrelated individuals with the same syndromic form of intellectual disability. BMC Biotechnol. 17, 90 (2017).
Article PubMed PubMed Central Google Scholar
Van der Donk, R. et al. Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders. Genet. Med. 21, 1719–1725 (2019).
Gurovich, Y. et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat. Med. 25, 60–64 (2019).
Article CAS PubMed Google Scholar
Dingemans, AJM et al. Quantitative facial phenotyping for Koolen-de Vries and 22q11.2 deletion syndrome.EUR.J. Hum.Genet.29, 1418–1423 (2021).
Article CAS PubMed PubMed Central Google Scholar
Hsieh, T.-C. et al. GestaltMatcher facilitates rare disease matching using facial phenotype descriptors. Nat. Genet. 54, 349–357 (2022).
Article CAS PubMed PubMed Central Google Scholar
Claes, P. et al. Genome-wide mapping of global-to-local genetic effects on human facial shape. Nat. Genet. 50, 414–423 (2018).
Article CAS PubMed PubMed Central Google Scholar
White, J. D. et al. Insights into the genetic architecture of the human face. Nat. Genet. 53, 45–53 (2021).
Article CAS PubMed Google Scholar
Naqvi, S. et al. Shared heritability of human face and brain shape. Nat. Genet. 53, 830–839 (2021).
Article CAS PubMed PubMed Central Google Scholar
Zhang, M. et al. Genetic variants underlying differences in facial morphology in East Asian and European populations. Nat. Genet. 54, 403–411 (2022).
Article CAS PubMed Google Scholar
Vulto-van Silfhout, A. T. et al. Clinical significance of de novo and inherited copy-number variation. Hum. Mutat. 34, 1679–1687 (2013).
Article CAS PubMed Google Scholar
Brier, G. W. Verification of forecasts expressed in terms of probability. Mon. Weather Rev. 78, 1–3 (1950).
Koolen, D. A. et al. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat. Genet. 44, 639–641 (2012).
Article CAS PubMed Google Scholar
Zollino, M. et al. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat. Genet. 44, 636–638 (2012).
Article CAS PubMed Google Scholar
Koolen, D. A. et al. The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. Eur. J. Hum. Genet. 24, 652–659 (2016).
Article CAS PubMed Google Scholar
Köhler, S. et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 47, D1018–D1027 (2019).
den Hoed, J. et al. Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction. Am. J. Hum. Genet. 108, 346–356 (2021).
Nabais Sá, M. J. et al. De novo and biallelic DEAF1 variants cause a phenotypic spectrum. Genet. Med. 21, 2059–2069 (2019).
Hoischen, A. et al.De novo mutations of SETBP1 cause Schinzel-Giedion syndrome.Nat.Genet.42, 483–485 (2010).
Article CAS PubMed Google Scholar
Filges, I. et al. Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome. J. Med. Genet. 48, 117–122 (2011).
Article CAS PubMed Google Scholar
Bend, E. G. et al. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Clin. Epigenetics 11, 64 (2019).
Article PubMed PubMed Central Google Scholar
Breen, M. S. et al. Episignatures stratifying Helsmoortel-Van Der Aa syndrome Show modest correlation with phenotype. Am. J. Hum. Genet. 107, 555–563 (2020).
Article CAS PubMed PubMed Central Google Scholar
Jagadeesh, K. A. et al. Phrank measures phenotype sets similarity to greatly improve Mendelian diagnostic disease prioritization. Genet. Med. 21, 464–470 (2019).
Article CAS PubMed Google Scholar
Lyra Jr, P. C. M. et al. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Genet. Med. 23, 306–315 (2021).
Article CAS PubMed Google Scholar
Frederiksen, J. H., Jensen, S. B., Tümer, Z. & Hansen, T. V. O. Classification of MSH6 variants of uncertain significance using functional assays. Int. J. Mol. Sci. 22, 8627 (2021).
Article CAS PubMed PubMed Central Google Scholar
Caswell, R. C., Gunning, A. C., Owens, M. M., Ellard, S. & Wright, C. F. Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory. Genome Med. 14, 77 (2022).
Article CAS PubMed PubMed Central Google Scholar
Dingemans, A. J. M. et al. Human disease genes website series: an international, open and dynamic library for up-to-date clinical information. Am. J. Med. Genet. A 185, 1039–1046 (2021).
Article PubMed PubMed Central Google Scholar
McKusick, V. A. Mendelian inheritance in man and its online version, OMIM. Am. J. Hum. Genet. 80, 588–604 (2007).
Article CAS PubMed PubMed Central Google Scholar
Firth, H. V. et al. DECIPHER: database of chromosomal imbalance and phenotype in humans using ensembl resources. Am. J. Hum. Genet. 84, 524–533 (2009).
Article CAS PubMed PubMed Central Google Scholar
Adam, MP et al.GeneReviews (University of Washington, 2010).
Helsmoortel, C. et al. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat. Genet. 46, 380–384 (2014).
Article CAS PubMed PubMed Central Google Scholar
Côté, R. A. & Robboy, S. Progress in medical information management. Systematized nomenclature of medicine (SNOMED). JAMA 243, 756–762 (1980).
Karras, T., Laine, S. & Aila, T. A style-based generator architecture for generative adversarial networks. IEEE Trans. Pattern Anal. Mach. Intell. 43, 4217–4228 (2021).
Manders, P., Lutomski, J. E., Smit, C., Swinkels, D. W. & Zielhuis, G. A. The Radboud biobank: a central facility for disease-based biobanks to optimise use and distribution of biomaterial for scientific research in the Radboud university medical center, Nijmegen. Open J. Bioresour. 5, 2 (2018).
Parkhi, O. M., Vedaldi, A. & Zisserman, A. Deep face recognition. Proceedings of the British Machine Vision Conference (eds Xianghua X. et al.) 41.1–41.12 (BMVA Press, 2015).
Cao, Q. Shen, L., Xie, W. Parkhi, O. M. & Zisserman, A. VGGFace2: a dataset for recognising faces across pose and age. Proceedings of 13th IEEE International Conference on Automatic Face & Gesture Recognition (F&G) pp. 67–74 (IEEE, 2018).
Dingemans, A. J. M., de Vries, B. B. A., Vissers, L. E. L., van Gerven, M. A. J. & Hinne, M. Comparing facial feature extraction methods in the diagnosis of rare genetic syndromes. Preprint at medRxiv https://doi.org/10.1101/2022.08.26.22279217 (2022).
Resnik, P. Semantic similarity in a taxonomy: an information-based measure and its application to problems of ambiguity in natural language. J. Artif. Intell. Res. 11, 95–130 (1999).
Pesquita, C. et al. Metrics for GO based protein semantic similarity: a systematic evaluation. BMC Bioinformatics 9, S4 (2008).
Article PubMed PubMed Central Google Scholar
Arvai, K., Gainullin, V. & Borroto, C. GeneDx/phenopy.Zenodo https://doi.org/10.5281/zenodo.4587231 (2019).
Ribeiro, M. T., Singh, S. & Guestrin, C. ‘Why should I trust you?’ Explaining the predictions of any classifier. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and DATA MINIng 1135–1144 (Association for Computing Machinery, 2016).
Ras, G., Xie, N., van Gerven, M. & Doran, D. Explainable deep learning: a field guide for the uninitiated. J. Artif. Intell. Res. 73, 329–396 (2022).
Köhler, S. et al. The human phenotype ontology in 2017. Nucleic Acids Res. 45, D865–D876 (2017).
Yuan, X. et al. Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases. Brief. Bioinform. 23, bbac019 (2022).
Article PubMed PubMed Central Google Scholar
Dingemans, L. ldingemans/PhenoScore: v1.0.0.Zenodo https://doi.org/10.5281/zenodo.7892317 (2023).
We are grateful to all families and clinicians who agreed to participate and provide clinical and genotypic information. R.F.K. acknowledges financial support from the Research Fund of the University of Antwerp (Methusalem-OEC grant GENOMED). The work of G.J.L. is supported by New York State Office for People with Developmental Disabilities (OPWDD) and NIH NIGMS R35-GM-133408. E.E.P. is supported by a National Health and Medical Research Council Investigator Grant (award 2021/GNT2008166). Furthermore, we are grateful to the Dutch Organization for Health Research and Development—ZON-MW grants 912-12-109 (to B.B.A.d.V. and L.E.L.M.V.), Donders Junior researcher grant 2019 (to B.B.A.d.V. and L.E.L.M.V.) and Aspasia grant 015.014.066 (to L.E.L.M.V.). The aims of this study contribute to the Solve-RD project (to L.E.L.M.V.), which has received funding from the European Unions Horizon 2020 research and innovation program under grant agreement 779257. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
These authors contributed equally: Lisenka E. L. M. Vissers, Bert B. A. de Vries.
Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands
Alexander JM Dingemans, Kim MG Truijen, Lia Goltstein, Jeroen van Reeuwijk, Nicole de Leeuw, Janneke Schuurs-Hoeijmakers, Rolph Pfundt, Illja J. Diets, Elke de Boer, Jet Coenen-van der Spek, Bregje W. van Bon, Noraly Jonis, Charlotte W. Ockeloen, Anneke T. Vulto-van Silfhout, Tjitske Kleefstra, David A. Koolen, Lisenka ELM Vissers & Bert BA de Vries
Department of Artificial Intelligence, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
Alexander JM Dingemans, Max Hinne & Marcel AJ van Gerven
Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
Faculty of Medicine and Health, UNSW Sydney, Sydney, New South Wales, Australia
Sydney Children’s Hospitals Network, Sydney, New South Wales, Australia
Center for Human Genetics, University Hospitals Leuven, University of Leuven, Leuven, Belgium
Department of Human Genetics and George A. Jervis Clinic, Institute for Basic Research in Developmental Disabilities (IBR), Staten Island, NY, USA
Biology PhD Program, The Graduate Center, The City University of New York, New York City, NY, USA
Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Institute of Medical Genetics, University of Zürich, Zürich, Switzerland
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
Faculty of Medicine, University of Southampton, Southampton, UK
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands
Pleuntje J. van der Sluijs & Gijs WE Santen
Department of Medical Genetics, University of Antwerp, Antwerp, Belgium
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
A.J.M.D., M.H., L.E.L.M.V., B.B.A.d.V. and M.A.J.v.G. designed the study. A.J.M.D., K.M.G.T., L.G., J.v.R., N.d.L., J.S.H., R.P., I.J.D., E.d.B., J.d.H., J.v.d.S., S.J., B.W.v.B., N.J., E.E.P., P.M.C., A.T.V.v.S., T.K., D.A.K., F.K., H.V.E., G.J.L., F.S.A., A.R., R.M., D.B., P.J.v.d.S., G.S., L.E.L.M.V. and B.B.A.d.V. collected and curated the data. A.J.M.D. and M.H. performed the formal analyses. L.E.L.M.V. and B.B.A.d.V. acquired the funding. A.J.M.D. and M.H. completed the modeling and investigations. A.J.M.D. developed the software. A.J.M.D., M.H., L.E.L.M.V., B.B.A.d.V. and M.A.J.v.G. wrote the original draft. All authors reviewed and edited the final manuscript.
Correspondence to Lisenka E. L. M. Vissers or Bert B. A. de Vries.
The authors declare no competing interests.
Nature Genetics thanks Xinran Dong and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The predictive accuracies of LIRICAL, Phenomizer and PhenoScore [118-120] for every included genetic syndrome are displayed here, except for ACTL6A, since the associated phenotype has no OMIM number and therefore Phenomizer and LIRICAL do not include it in its predictions. For PhenoScore and LIRICAL, to calculate the accuracy, a cut-off value of 0.5 for the predictions was used, while for Phenomizer in this case, 0.05 was chosen. For almost every investigated syndrome, PhenoScore outperforms Phenomizer and LIRICAL.
The receiver operating characteristic curve of all 40 genetic syndromes included in this study.
The Uniform Manifold Approximation and Projection for Dimension Reduction (UMAP3) plot for the VGGFace2 vectors of all included genetic syndromes, and for the extra systematic confounder analysis for which the individuals with Koolen-de Vries syndrome seen at other centers were compared to individuals seen at our outpatient clinic. For all plots (except the KANSL1 internal/external plot), the feature vectors of all sampled controls during five iterations and the feature vectors of the included patients were provided as input to UMAP. The classes are not separable in this projected space, which provides evidence that the classification is not based on a systematic confounder.
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Dingemans, A.J.M., Hinne, M., Truijen, K.M.G. et al. PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework. Nat Genet 55, 1598–1607 (2023). https://doi.org/10.1038/s41588-023-01469-w
DOI: https://doi.org/10.1038/s41588-023-01469-w
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
European Journal of Human Genetics (2023)
Nature Genetics (Nat Genet) ISSN 1546-1718 (online) ISSN 1061-4036 (print)
Equipment For Tattoo Tattoo Removal Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.